Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The ...

Scientists at the UVA Comprehensive Cancer Center say they have found a small molecule that can shut down a gene tied to glioblastoma, a discovery that could eventually point to a new way to treat ...

In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, ...

Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

The onset and aggressiveness of cancer are related to the abnormal behaviour of certain genes, known as oncogenes. The best-known of these alterations ...

Perioperative therapy has become a critical component in the management of resectable non–small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is ...

Dr. Mariano Barbacid, a pioneering Spanish cancer scientist, alongside his team have eliminated aggressive pancreatic tumours in mice using a triple-drug therapy targeting the KRAS pathway. While not ...

By targeting a cancer-driving pathway at multiple steps, a triple therapy stopped pancreatic tumors from developing ...